| |
 |
|
Class Information
Number: 424/186.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus
Description: Subject matter wherein the disclosed amino acid sequence is derived from a viral protein or fragment thereof.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6010700 |
Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
Jan. 4, 2000 |
| 6004557 |
Variants of human papillomavirus antigens |
Dec. 21, 1999 |
| 6004763 |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
Dec. 21, 1999 |
| 5989554 |
High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
Nov. 23, 1999 |
| 5985283 |
Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation |
Nov. 16, 1999 |
| 5980899 |
Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells |
Nov. 9, 1999 |
| 5965139 |
Chicken infectious anemia virus vaccine |
Oct. 12, 1999 |
| 5965134 |
Immunogenic composition against Classical Swine Fever Virus (CSFV) |
Oct. 12, 1999 |
| 5965138 |
Recombinant chimeric virus and uses thereof |
Oct. 12, 1999 |
| 5958895 |
DNA vaccines for herpes simplex virus |
Sep. 28, 1999 |
| 5952002 |
Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
Sep. 14, 1999 |
| 5925733 |
DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
Jul. 20, 1999 |
| 5919454 |
Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
Jul. 6, 1999 |
| 5888513 |
Recombinant PRRSV proteins, diagnostic kits and vaccines containing such recombinant PRRSV proteins |
Mar. 30, 1999 |
| 5885585 |
Attenuated canine parvovirus vaccine |
Mar. 23, 1999 |
| 5876723 |
Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition |
Mar. 2, 1999 |
| 5874087 |
Modified plant viruses as vectors |
Feb. 23, 1999 |
| 5874089 |
Protecting against canine oral papillomavirus (copy) |
Feb. 23, 1999 |
| 5874526 |
Toxoplasma gondii antigens |
Feb. 23, 1999 |
| 5871998 |
Self-assembling recombinant papillomavirus capsid proteins |
Feb. 16, 1999 |
| 5871996 |
Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis |
Feb. 16, 1999 |
| 5871744 |
Method for generating birnavirus from synthetic RNA transcripts |
Feb. 16, 1999 |
| 5871740 |
Methods of using poxvirus p35 as a chemokine inhibitor and compositions therefore |
Feb. 16, 1999 |
| 5871747 |
Antigen-carrying microparticles and their use in the indication of humoral or cellular responses |
Feb. 16, 1999 |
| 5866131 |
Recombinant vaccine |
Feb. 2, 1999 |
| 5864008 |
Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides |
Jan. 26, 1999 |
| 5861243 |
Vaccine for protection against HIV infections, process for preparing same and their use as diagnostic and agent immunotherapeutic agent |
Jan. 19, 1999 |
| 5858373 |
Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
Jan. 12, 1999 |
| 5853734 |
Glycoprotein L and clycoprotein M from kaposi's sarcoma associated herpesvirus, DNA encoding same and uses thereof |
Dec. 29, 1998 |
| 5854398 |
Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof |
Dec. 29, 1998 |
| 5843706 |
Vaccines against animal parasitic nematodes |
Dec. 1, 1998 |
| 5840305 |
Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity |
Nov. 24, 1998 |
| 5840304 |
T-cell receptor .beta.subunit polypeptides |
Nov. 24, 1998 |
| 5837262 |
Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque |
Nov. 17, 1998 |
| 5837249 |
Method for generating an immunogenic T cell response protective against a virus |
Nov. 17, 1998 |
| 5827518 |
Viral and insect genes that inhibit the immune system and methods of use thereof |
Oct. 27, 1998 |
| 5824506 |
Dengue virus peptides and methods |
Oct. 20, 1998 |
| 5820870 |
Recombinant human papillomavirus type 18 vaccine |
Oct. 13, 1998 |
| 5821087 |
Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA |
Oct. 13, 1998 |
| 5814486 |
Herpes simplex virus glycoprotein D variants |
Sep. 29, 1998 |
| 5814510 |
Attenuated canine parvovirus vaccine |
Sep. 29, 1998 |
| 5811104 |
Recombinant structural and non-structural proteins of FIPV and method of immunizing |
Sep. 22, 1998 |
| 5807552 |
Compositions for conferring immunogenicity to a substance and uses thereof |
Sep. 15, 1998 |
| 5788969 |
Peptides for inducing cytotoxic T lymphocyte responses hepatitis B virus |
Aug. 4, 1998 |
| 5785974 |
Synthetic peptides and vaccines against parvovirus |
Jul. 28, 1998 |
| 5785973 |
Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
Jul. 28, 1998 |
| 5780036 |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus |
Jul. 14, 1998 |
| 5773235 |
Equine arteritis virus peptides; antibodies and their use in a diagnostic test |
Jun. 30, 1998 |
| 5760175 |
Peptide to detect several herpes virus infections |
Jun. 2, 1998 |
| 5756284 |
Self-assembling recombinant papillomavirus capsid proteins |
May. 26, 1998 |
|
|
|